Regentis Biomaterials Ltd (RGNT)

$6.10 -3.30 (-35.11%)
Market Cap 48.69M
Revenue (ttm) 0.00
Net Income (ttm) -13.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 8,384,300
Avg Vol 6,440,032
Day's Range N/A - N/A
Shares Out 5.18M
Stochastic %K 34%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 972 9 960 1917
Address:
60, Medinat Hayehudim, Entrance C Herzlia Pituach, Herzliya, Israel
Mmssmm
Mmssmm Jun. 17 at 5:22 AM
$QNCX this stock needs a big bounce to $5 a share Like $RGNT $LNAI Please let’s do it NEVER EVER GIVE UP NEVER
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 17 at 3:40 AM
$RGNT looks like it might come down to $4. definitely a good one though. $20 is coming
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 17 at 2:18 AM
$DSY $WCT.X $RGNT $QTEX $GPUS
0 · Reply
Bullbear1010101
Bullbear1010101 Jun. 17 at 1:10 AM
$RGNT hope not true
0 · Reply
trustee101
trustee101 Jun. 17 at 12:59 AM
$RGNT I see this going to 3$
0 · Reply
FLn00b
FLn00b Jun. 17 at 12:24 AM
$RGNT Who didn't listen lol
0 · Reply
Marlala
Marlala Jun. 16 at 11:05 PM
$RGNT nothing has changed 🙌
1 · Reply
Mark_Etmaker
Mark_Etmaker Jun. 16 at 10:53 PM
$RGNT might see it pop here, got your ears on bandit?? 🚛🚛🏎️🚓
0 · Reply
bmorgan1227
bmorgan1227 Jun. 16 at 10:49 PM
$RGNT more low volume walk downs, but no buyers to prop it up
0 · Reply
johnnylawrencecobra
johnnylawrencecobra Jun. 16 at 10:35 PM
$GIFT $RGNT $SNDK
0 · Reply
Latest News on RGNT
Why Is Regentis Biomaterials Stock (RGNT) Up Today?

2026-06-15T17:27:31.000Z - 1 day ago

Why Is Regentis Biomaterials Stock (RGNT) Up Today?

Regentis Biomaterials Ltd trading resumes

2026-06-15T16:25:07.000Z - 1 day ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, news pending

2026-06-15T15:48:28.000Z - 1 day ago

Regentis Biomaterials Ltd trading halted, news pending

Regentis Biomaterials to commence European surgeon training for GelrinC

2026-06-08T12:41:04.000Z - 8 days ago

Regentis Biomaterials to commence European surgeon training for GelrinC

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

Jun 8, 2026, 8:32 AM EDT - 8 days ago

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

2026-04-16T12:51:22.000Z - 2 months ago

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Apr 16, 2026, 8:30 AM EDT - 2 months ago

Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon

Regentis Biomaterials develops and patents solvent-free manufacturing process

2026-03-17T13:07:43.000Z - 3 months ago

Regentis Biomaterials develops and patents solvent-free manufacturing process

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Mar 17, 2026, 8:30 AM EDT - 3 months ago

Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%

Regentis Biomaterials initiated with a Buy at ThinkEquity

2026-03-02T11:39:51.000Z - 3 months ago

Regentis Biomaterials initiated with a Buy at ThinkEquity

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Feb 24, 2026, 4:15 PM EST - 4 months ago

Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update

Regentis Biomaterials appoints Galit Reke as CMO

2026-02-19T13:57:38.000Z - 4 months ago

Regentis Biomaterials appoints Galit Reke as CMO

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Feb 19, 2026, 8:30 AM EST - 4 months ago

Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair

Regentis Biomaterials expands European clinical site network

2026-02-17T13:45:16.000Z - 4 months ago

Regentis Biomaterials expands European clinical site network

Regentis Biomaterials appoints Ori Gon as CFO, CBO

2026-02-04T14:01:34.000Z - 4 months ago

Regentis Biomaterials appoints Ori Gon as CFO, CBO

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Feb 4, 2026, 8:33 AM EST - 4 months ago

Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial

Regentis Biomaterials expanding Phase III GelrinC clinical site network

2026-01-29T13:50:51.000Z - 4 months ago

Regentis Biomaterials expanding Phase III GelrinC clinical site network

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Jan 29, 2026, 8:33 AM EST - 4 months ago

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

Regentis Biomaterials Ltd trading resumes

2026-01-28T16:25:13.000Z - 4 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-28T16:05:14.000Z - 4 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Regentis Biomaterials announces long-term imaging data on GelrinC

2026-01-20T14:00:22.000Z - 5 months ago

Regentis Biomaterials announces long-term imaging data on GelrinC

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Jan 20, 2026, 8:33 AM EST - 5 months ago

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

Regentis Biomaterials Ltd trading resumes

2026-01-16T16:05:30.000Z - 5 months ago

Regentis Biomaterials Ltd trading resumes

Regentis Biomaterials Ltd trading halted, volatility trading pause

2026-01-16T16:00:15.000Z - 5 months ago

Regentis Biomaterials Ltd trading halted, volatility trading pause

Regentis Biomaterials announces publication of GelrinC follow-up results

2026-01-06T14:00:16.000Z - 5 months ago

Regentis Biomaterials announces publication of GelrinC follow-up results

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Jan 6, 2026, 8:21 AM EST - 5 months ago

Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation

Regentis Biomaterials granted U.S. patent for GelrinC

2025-12-18T13:50:22.000Z - 6 months ago

Regentis Biomaterials granted U.S. patent for GelrinC

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Dec 18, 2025, 8:35 AM EST - 6 months ago

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

Opening Day: Regentis Biomaterials raises $10M in IPO

2025-12-08T15:30:10.000Z - 6 months ago

Opening Day: Regentis Biomaterials raises $10M in IPO

HYNE PARK POAS SMJF

Regentis Biomaterials commences trading on NYSE

2025-12-08T13:55:06.000Z - 6 months ago

Regentis Biomaterials commences trading on NYSE

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Dec 5, 2025, 4:10 PM EST - 6 months ago

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Dec 3, 2025, 7:23 PM EST - 6 months ago

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Mar 11, 2025, 9:16 AM EDT - 1 year ago

Israeli hydrogel implant developer Regentis Biomaterials files and sets terms for a $10 million US IPO

Regentis Biomaterials IPO Registration Document (F-1)

Mar 11, 2025, 6:09 AM EDT - 1 year ago

Regentis Biomaterials IPO Registration Document (F-1)

Mmssmm
Mmssmm Jun. 17 at 5:22 AM
$QNCX this stock needs a big bounce to $5 a share Like $RGNT $LNAI Please let’s do it NEVER EVER GIVE UP NEVER
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 17 at 3:40 AM
$RGNT looks like it might come down to $4. definitely a good one though. $20 is coming
0 · Reply
Sw1ngb0t
Sw1ngb0t Jun. 17 at 2:18 AM
$DSY $WCT.X $RGNT $QTEX $GPUS
0 · Reply
Bullbear1010101
Bullbear1010101 Jun. 17 at 1:10 AM
$RGNT hope not true
0 · Reply
trustee101
trustee101 Jun. 17 at 12:59 AM
$RGNT I see this going to 3$
0 · Reply
FLn00b
FLn00b Jun. 17 at 12:24 AM
$RGNT Who didn't listen lol
0 · Reply
Marlala
Marlala Jun. 16 at 11:05 PM
$RGNT nothing has changed 🙌
1 · Reply
Mark_Etmaker
Mark_Etmaker Jun. 16 at 10:53 PM
$RGNT might see it pop here, got your ears on bandit?? 🚛🚛🏎️🚓
0 · Reply
bmorgan1227
bmorgan1227 Jun. 16 at 10:49 PM
$RGNT more low volume walk downs, but no buyers to prop it up
0 · Reply
johnnylawrencecobra
johnnylawrencecobra Jun. 16 at 10:35 PM
$GIFT $RGNT $SNDK
0 · Reply
come_litaliano
come_litaliano Jun. 16 at 10:25 PM
$RGNT Let me remind you of something critical. Yesterday's volume was about 180.97 million. And today the volume barely managed to pass 8 million. And you know what that means?! 99.5% of institutional traders including retail traders have deleted the stock from their system and moved on to the next stock. Therefore, this stock is on the way to clinical death. And here it is happening right now.
2 · Reply
Mark_Etmaker
Mark_Etmaker Jun. 16 at 10:05 PM
$RGNT well, maybe tomorr-blow
0 · Reply
come_litaliano
come_litaliano Jun. 16 at 9:49 PM
$RGNT That won't happen. With the poor volume today compared to the crazy volume yesterday, it looks like the stock is about to return to its rightful price. On its way to $1.3
0 · Reply
CDG757
CDG757 Jun. 16 at 9:36 PM
$RGNT no matter what the price is tomorrow you don’t lose if you don’t sell….
0 · Reply
sndbnd
sndbnd Jun. 16 at 9:28 PM
$RGNT or it will gain $3.X tomorrow and the price will be 9+
2 · Reply
SexyStockSlayer
SexyStockSlayer Jun. 16 at 9:03 PM
$RGNT in for the reversal tomorrow!
0 · Reply
ThaDankles
ThaDankles Jun. 16 at 8:56 PM
$VTGN we bout to pop like $RGNT just did. Gonna be epic!
0 · Reply
RoaringSwissKitty
RoaringSwissKitty Jun. 16 at 8:45 PM
$RGNT
0 · Reply
come_litaliano
come_litaliano Jun. 16 at 8:42 PM
$RGNT Here's a simple calculation. The stock lost $3 in value today. And so it will repeat itself tomorrow. So the price tomorrow is $3
0 · Reply
Dizzy8
Dizzy8 Jun. 16 at 8:29 PM
$RGNT
0 · Reply
come_litaliano
come_litaliano Jun. 16 at 8:20 PM
$RGNT @thatsabingo1 It turns out there are people here who didn't finish third grade math, so go figure out how they even trade stocks?! There's no shortage of idiots here.😂😂😂
1 · Reply
thatsabingo1
thatsabingo1 Jun. 16 at 8:11 PM
$RGNT you do understand that a drop from 20 to 6 is like a 70% drop right?
1 · Reply